Adrian Israelson

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Venues

Biomolecules

ACS chemical neuroscience

International journal of molecular sciences

Proceedings of the National Academy of Sciences of the United States of America

Ben-Gurion University of the Negev

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Ben-Gurion University of the Negev Mar 01 2018

Israel

Associate Professor :: Physiology and Cell Biology

Ben-Gurion University of the Negev Oct 01 2012 - Feb 28 2018

Israel

Assistant Professor :: Physiology and Cell Biology

University of California San Diego Mar 01 2007 - Sep 30 2012

United States

Postdoctoral researcher :: Cellular and Molecular Medicine

Publications

Sigal Fleisher-Berkovich, Yvonne Ventura, Maya Amoyal, Arik Dahan, Valeria Feinshtein, Leenor Alfahel, Adrian Israelson, Nirit Bernstein, Jonathan Gorelick, Shimon Ben-Shabat
Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo. Biomolecules 13 (2) (2023)
Sigal Fleisher-Berkovich, Yvonne Ventura, Maya Amoyal, Arik Dahan, Valeria Feinshtein, Leenor Alfahel, Adrian Israelson, Nirit Bernstein, Jonathan Gorelick, Shimon Ben-Shabat
Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo. Biomolecules 13 (2) (2023)
Sigal Fleisher-Berkovich, Yvonne Ventura, Maya Amoyal, Arik Dahan, Valeria Feinshtein, Leenor Alfahel, Adrian Israelson, Nirit Bernstein, Jonathan Gorelick, Shimon Ben-Shabat
Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo. Biomolecules 13 (2) (2023)
Sigal Fleisher-Berkovich, Yvonne Ventura, Maya Amoyal, Arik Dahan, Valeria Feinshtein, Leenor Alfahel, Adrian Israelson, Nirit Bernstein, Jonathan Gorelick, Shimon Ben-Shabat
Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo. Biomolecules 13 (2) (2023)
Anna Shteinfer-Kuzmine, Shirel Argueti-Ostrovsky, Marcel F Leyton-Jaimes, Uttpal Anand, Salah Abu-Hamad, Ran Zalk, Varda Shoshan-Barmaz, Adrian Israelson
Targeting the Mitochondrial Protein VDAC1 as a Potential Therapeutic Strategy in ALS. International journal of molecular sciences 23 (17) (2022)
Leenor Alfahel, Shirel Argueti-Ostrovsky, Shir Barel, Mahmood Ali Saleh, Joy Kahn, Salome Azoulay-Ginsburg, Ayelet Rothstein, Simon Ebbinghaus, Arie Gruzman, Adrian Israelson
4-Phenylbutyric Acid (4-PBA) Derivatives Prevent SOD1 Amyloid Aggregation In Vitro with No Effect on Disease Progression in SOD1-ALS Mice. International journal of molecular sciences 23 (16) (2022)
Shirel Argueti-Ostrovsky, Leenor Alfahel, Joy Kahn, Adrian Israelson
All Roads Lead to Rome: Different Molecular Players Converge to Common Toxic Pathways in Neurodegeneration. Cells 10 (9) (2021)
Shamchal Bakavayev, Shirel Argueti, Nachiyappan Venkatachalam, Galit Yehezkel, Alexandra Stavsky, Zeev Barak, Adrian Israelson, Stanislav Engel
Exposure of β6/β7-Loop in Zn/Cu Superoxide Dismutase (SOD1) Is Coupled to Metal Loss and Is Transiently Reversible During Misfolding. ACS chemical neuroscience 12 (1) (2020)
Marcel F Leyton-Jaimes, Joy Kahn, Adrian Israelson
AAV2/9-mediated overexpression of MIF inhibits SOD1 misfolding, delays disease onset, and extends survival in mouse models of ALS. Proceedings of the National Academy of Sciences of the United States of America 116 (29) (2019)
Salah Abu-Hamad, Joy Kahn, Marcel F Leyton-Jaimes, Jonathan Rosenblatt, Adrian Israelson
Misfolded SOD1 Accumulation and Mitochondrial Association Contribute to the Selective Vulnerability of Motor Neurons in Familial ALS: Correlation to Human Disease. ACS chemical neuroscience 8 (10) (2017)

Adrian Israelson.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Adrian Israelson